Medicines
Hitherto, EU law has in effect made provision for two different procedures when registering medicinal products (i) registration with the competent authority in the member state (for instance, following the accession of CR to the EU, by the Medicinal Products State Inspection Office in the CR) and (ii) registration via a centralised evaluation body (European Medicines Evaluation Agency, London).
The two new regulations set out the steps for variations in marketing authorisations applicable under both procedures. The intention is to simplify and expedite procedures for certain types of variations in registration, as well as to clarify legislation in this area. Upon registration in a member state, the variation will be examined by a competent authority of the member state. Provisions governing administrative procedures and requirements for variation of registration will differ according to the type of variation, as set out in the attached schedules. Procedures have been simplified, particularly where there is a need to adopt emergency measures or to combat an influenza pandemic.
Commission Directive 2003/94/EC of 8 October 2003 setting out the principles and guidelines for good manufacturing practice relating to medicinal products for human use
Official Journal of the EU L 262 of 14 October 2003
This Directive introduced a change in the requirements relating to correct manufacture of medicinal products intended for human use and replaces existing Directive 91/356/EEC. It incorporates new provisions on the rights of supervisory bodies to carry out inspections, quality control and other matters requiring attention following experience in implementing the existing provisions. At national level the Directive is mostly reflected in secondary legislation. The deadline for implementation of the Directive into national legal order expires on 30 April 2004.
Other articles
Helena Navrátilová on Three Decades of the Advent Concerts of Good Will
KŠB partner Helena Navrátilová was recently interviewed on S dobrou vůlí, the podcast of the Committee of Good Will – Olga Havel Foundation. Speaking with editor Veronika Širc, Helena talked about the origins and history of the Advent Concerts of Good Will, which KŠB has been organizing for over thirty years.
KŠB advises the founders on the sale of the LIPOELASTIC Group
KŠB, in collaboration with investment advisers from the Roklen Group, advised LIPOELASTIC Group founders Alena and Tomáš Hradil on their exit from the group, which they had built up over almost twenty-five years.
Chemistry Brings People Together: KŠB at the 2026 Evening of Czech Chemistry
Czech chemistry and the chemical industry are built on innovation, responsibility and the people who drive the field forward. On Thursday, 22 October 2026, leading figures from the field and industry representatives came together at the Grand Hotel International Prague for the Czech Chemical Industry Association’s annual Evening of Czech Chemistry.
